Latest osteosarcoma Stories
NEW YORK, April 29 /PRNewswire-USNewswire/ -- The Sarcoma Foundation of America (SFA)'s Eighth Annual Fundraising Gala on Monday, April 26, raised more than $925,000, an all-time record for the non-profit group dedicated to increasing research that will find new and better therapies for patients with sarcoma, a rare connective tissue cancer.
Nine-year-old Morgan LaRue is the first cancer patient in Texas to benefit from a groundbreaking procedure that will magnetically lengthen her leg, sparing her the possibility of up to 10 future surgeries as her body grows.
TGen and VARI study cancer in dogs to find new treatments for humans.
Dr. Tsz-Kwong Man, a researcher with the Texas Children's Cancer Center at Baylor College of Medicine, has a received a grant from the Liddy Shriver Sarcoma Initiative to study the function of a protein that may promote the spread of a common form of children's bone cancer called osteosarcoma.
A drug already approved for the treatment of lymphoma may also slow the growth of the most deadly bone cancer in children and teens.
SAN MARINO, Calif., Oct. 12 /PRNewswire/ -- Epeius Biotechnologies Corporation today announced more stunning results of its pioneering clinical studies of Rexin-G, the world's first and, so far only, tumor-targeted genetic medicine to be validated in the clinic.
A team of Israeli researchers say they have developed a new drug carrier to deliver compounds straight to a tumor to starve it of blood. Dr.
New TAU drug cuts off blood supplies to starve cancer tumors.
ROCKLEIGH, N.J., Sept.
A new analysis suggests patients and physicians should rethink the pros and cons of limb-sparing surgery versus amputation for bone and soft tissue sarcomas of the lower limb.
- The act of sweetening by admixture of some saccharine substance.